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We are interested in studying how influenza virus escapes antibody inhibition. Based on the structure of the complex
between N9 NA and monoclonal antibody NC10 Fab (R. L. Malby, W. R. Tulip, V. R. Harley, J. L. McKimm-Breschkin, W. G. Laver,
R. G. Webster, and P. M. Colman, 1994, Structure 2, 733–746), we investigated the contribution made by individual amino acids
to the stability of the complex. We made conservative changes in residues that are centrally located in the epitope and more
drastic changes in peripheral contacts. The mutations made were N200L (removing an N-linked oligosaccharide), N329Q,
N345Q, S370T, S372A, N400L, and K432M. Binding of each mutant to NC10 was quantitated by NA inhibition assays and
ELISA. Except for N200L and N329Q, the mutants were inhibited by NC10 to the same extent as wild-type NA although with
less affinity. The enzyme activity (Kcat) of N200L is 80% reduced, indicating a defect in folding or assembly; therefore, the loss
in binding activity due to the missing sugar residue cannot be assessed. The Kd for N329Q is sixfold higher than for wild-type
NA in the inhibition test, but the same as wild-type in ELISA, indicating a change in disposition of the antibody but no loss
of affinity. The results show that the NC10 epitope can accommodate a change at any site and is not dominated by a few
high-energy interactions as was found in the NC41 epitope. We propose that the difference lies in the contribution of buriedINTRODUCTION
Influenza is a major disease and a leading cause of
death in the United States, with infants, immunosup-
pressed persons, and the elderly especially susceptible.
Influenza virus is a negative-stranded RNA virus belong-
ing to the family Orthomyxoviridae. Influenza has two
major surface glycoproteins, hemagglutinin (HA) and
neuraminidase (NA). Hemagglutinin binds to sialic acid
receptors while neuraminidase cleaves sialic acid from
the progeny virions and cell surface and so allows the
release and spread of virus (Liu et al., 1995; Palese et al.,
1974). The RNA polymerase of influenza has a high error
rate and, under antibody selection, these two surface
glycoproteins rapidly accumulate mutations. Thus, there
is a need every year to reformulate vaccines against the
virus. Neutralizing antibodies directed against HA mostly
prevent HA from interacting with sialic acid receptors
(Bizebard et al., 1995; Fleury et al., 1999; Wiley et al.,
1981). Antibodies against NA, while not inhibiting virus
entry, prevent spread of the virus and so protect against
challenge with the same or similar virus (Webster et al.,
1988).
NA is a tetramer of identical subunits anchored in the
lipid bilayer by a hydrophobic amino-terminal sequence
(reviewed in Air and Laver, 1989). Each monomer of the
1255box-shaped fourfold symmetric head consists of six four-
stranded antiparallel -sheets arranged in a propeller
fashion (Varghese et al., 1983). The active site of the
enzyme is located in a depression on top of each mono-
mer.
The 2.5 Å crystal structure of N9 NA from influenza
virus A/tern/Australia/G70c/75 complexed with NC41 Fab
shows 19 NA residues contacting 17 NC41 amino acids
(Colman et al., 1987; Tulip et al., 1989, 1992a). All but one
of the escape mutants selected with a panel of mono-
clonal antibodies to the NA contained a single amino
acid change, located on the top of the NA near the rim of
the active site depression (Webster et al., 1987). Those
mutants that did not bind to NC41 had single changes of
amino acids on the NA that were directly in contact with
NC41. Of 19 escape mutants selected by NC41 in inde-
pendent experiments, 10 were at residue 373, six at 368,
and two at 400. One other escape mutant had two
changes, at residues 434 and 437 (Air et al., 1990).
Since there was such a limited number of positions
where the escape mutants were selected, it was hypoth-
esized that the antibody selection process may be very
rigorous, with only changes in residues crucial for the
interaction being enough to abolish binding and allow
escape from antibody inhibition (Air et al., 1990). This
was demonstrated for the NC41 epitope by Nuss and
colleagues, using site-directed mutagenesis of NA. Ofwater molecules to the NA-NC10 complex. © 2002 Elsevier S
Key Words: influenza; antibody binding; epitope.
To whom correspondence and reprint requests should be ad-
dressed. Fax: 405-271-3205. E-mail: gillian-air@ouhsc.edu.
doi:10.1006/viro.2002.1564USA)
the 19 residues of N9 NA that contact NC41, only the side
chains of Ser368, Asn400, and Lys434 were critical such
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that even the most conservative changes abolished bind-
ing (Nuss et al., 1993). The other sites of contact could
accommodate at least some substitutions with little ef-
fect on activity.
To see if the interaction between NA and Fab being
mediated by just a few critical contacts is a more general
phenomenon, we have investigated the complex be-
tween NA and another antibody, NC10. The crystal struc-
ture of the N9 NA–NC10 Fab complex has been deter-
mined and refined to 2.5 Å (Malby et al., 1994). We made
changes designed to be conservative in the central part
of the epitope, and more drastic changes in the periph-
eral part of the epitope. These included conservative
changes made at known sites of escape mutations. We
also made a mutation to remove an N-linked carbohy-
drate chain on NA that makes contact with NC10 and so
forms part of the epitope.
Of the total contact surface of the epitope, polar con-
tacts make up 54%, hydrophobic contacts 38%, and
charged contacts 8% (Tulip et al., 1994). The contacts
mutated in this study and their percentage of the total
contact surface are as follows: Asn329 10%, Ser370 2%,
Ser372 1%, Asn400 8%, and Lys432 5%. The high-man-
nose carbohydrate attached to Asn200 of the adjacent
subunit accounts for 11% of the buried surface; Man200D
makes up 2% of the contact surface of the NA, Man200E
3%, and Man200F 6% (Tulip et al., 1994).
RESULTS
Mutagenesis and expression of wild-type and mutant
NA
We examined the crystal structure of the complex
between N9 NA and NC10 Fab (Malby et al., 1994) and
designed mutations at six NA residues identified as
forming hydrogen bonds and one that participates in a
salt bridge with the Fab. We designed the mutations to
cause minimal disruption of the overall structure. To test
the concept of a critical core of interactions, we made
very conservative changes in the central part of the
epitope (where side chains are 100% buried by the inter-
action with NC10) and more drastic changes at the pe-
ripheral contacts. Some escape mutants, selected with
other antibodies, that did not bind to NC10 (Webster et
al., 1987) are in the peripheral region (less than 100%
burying of solvent-exposed side chains), so we made
conservative changes in these. Mutant N200L was de-
signed to remove the N-linked carbohydrate attached to
N200 while substituting a significant mass at that site.
This carbohydrate chain forms part of the epitope on a
neighboring monomer, making several contacts between
the NA subunits and six contacts with NC10. Mutant
N345Q served as a negative control, since Asn345 does
not contact NC10. Although there are four additional
residues which contact NC10, the contacts involve only
TABLE 1
Mutations Made in N9 NA
Mutant
(N2 numbering) N9 number Background Rationale
N200La 200 Has a carbohydrate attached which forms part of the epitope in
a neighboring NA monomer. This carbohydrate makes two
hydrogen bonds with NA and multiple van der Waals
contacts with NA and NC10.
Removes the carbohydrate, replacing
it with a bulky hydrophobic chain.
N329Q 327 Makes three hydrogen bonds to NC10. Also, N329D was
selected by NC10 as an escape mutant.
Conservative change to try to
preserve hydrogen bonds.
N345Q 343 Irrelevant change. Conservative change here serves as
negative control for mutagenesis
and inhibition assays.
S370T 369 Makes two hydrogen bonds with NC10. The escape mutant
S270L selected by mAb 32/3 markedly reduced binding to
NC10.
Preserves hydrogen bonds.
S372A 371 Makes one hydrogen bond with NC10. Escape mutant S372Y
selected by antibody NC44 showed reduced binding to
NC10.
Replaces with nonpolar side chain to
make a nonconservative mutation
on this peripheral residue.
N400L 400 Makes one hydrogen bond with NC10. Escape mutant N400K
selected by antibody NC42 bound NC10 similar to wild-type.
Replaces with nonpolar side chain to
make a nonconservative mutation
on this peripheral residue.
K432M 430 Forms a salt link with NC10 Fab H chain. Removes charge, retains size.
a Mutants are named as the one letter code for the wild-type amino acid followed by the substitution made. The N2 numbering system was used
to allow easy comparison with the structure; the corresponding N9 NA positions are also given in parentheses. Escape mutant data are from Webster
et al. (1987).
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main chain atoms (Malby et al., 1994), and so mutations
were not made at these residues. The rationale for de-
signing each mutation is explained in Table 1.
The NA gene cloned into the vector pBluescript down-
stream of the T7 promoter (Air et al., 1985) was mutated
using the Chameleon Double-Stranded Site-Directed
Mutagenesis Kit (Stratagene). The mutant N200L was
made using the QuikChange Kit (Stratagene). The mutant
NA genes were sequenced completely to determine that
the desired mutation, and no others, were present, then
transfected into confluent HeLa cells infected with the
recombinant vaccinia virus vvTF7-3. The vvTF7-3 virus
encodes the T7 RNA polymerase, which expresses the
wild-type or mutant NA genes with high efficiency (Fuerst
et al., 1986).
Influenza NA cannot be expressed in native form in
Escherichia coli or other high-yield systems, and so we
have developed methods to quantitate the binding of
mutant NAs expressed on a mammalian cell surface to
NC10. These procedures extend those developed for
enzyme kinetic assays (Ghate and Air, 1998). We quan-
titated wild-type or mutant NA expressed by the trans-
fected HeLa cells by Western blot of detergent lysates of
the cells using standards of purified whole virus in which
the NA proportion was 5% of total viral protein as mea-
sured by scanning a stained protein gel. The Western
blot showed that all of the mutant proteins were ex-
pressed within a narrow concentration range (Fig. 1).
Determination of the amount of NA in the HeLa cell
lysate together with NA enzyme assays, using the thio-
barb assay with fetuin as substrate, allowed us to deter-
mine the specific enzyme activity of each expressed NA.
All but one of the mutants have 50% of wild-type NA
activity, expressed as Kcat (Table 2). The exception was
mutant N200L, which has less than 20% of wild-type
enzyme activity.
Kd of wild-type and mutant NA binding to NC10
We determined Kd in two different ways: by measuring
antibody inhibition of NA enzyme activity and by ELISA.
The wild-type NA activity was inhibited by NC10 up to
85% and all the mutant NAs were inhibited by NC10 to
within 5% of wild-type NA (Fig. 2A). However, expansion
of the first part of the binding curves shows that there are
TABLE 2
Specific Activities and Binding to NC10 by Wild-type
and Mutant NA
NA Kcat (s
1)
Binding to NC10
Kd (app)
a from NI
Scatchard (nM) (R2)
Kd (app) from
ELISA (nM) (R2)
Wt 0.27 0.04b 6.8 (0.98)c 0.51 (0.89)
N200L 0.05 0.01 26.5 (0.90) 4.30 (0.68)
N329Q 0.53 0.17 38.5 (0.93) 0.36 (0.97)
N345Q 0.26 0.05 10.9 (0.96) 0.43 (0.91)
S370T 0.12 0.01 9.1 (0.95) 0.60 (0.89)
S372A 0.14 0.04 11.9 (0.96) 0.24 (0.61)
N400L 0.14 0.04 12.0 (0.92) 1.29 (0.84)
K432M 0.17 0.04 8.9 (0.94) 0.54 (0.91)
a The apparent Kd is calculated for one binding site, i.e., using one
monomer of NA and a half antibody molecule. We previously showed
that there is little cooperativity between sites (Pruett et al., 1998).
b Kcat was calculated from enzyme activity with fetuin as substrate
and the amount of NA as determined by Western blot. It is calculated
per active site, i.e., one monomer of NA.
c Values in parentheses are the fit of the linear regression, calculated
in Microsoft Excel using the formula R 2  1 ¥ Yi  Yˆi
2/¥ Y i
2 
¥ Y i
2/n	 .
FIG. 1. Determination of amount of wild-type and mutant NAs by
Western blot. Thirty-five-millimeter plates of confluent HeLa cells were
infected with the recombinant vaccinia virus expressing T7 polymerase
(vvTF7-3) and then transfected with the pBluescript-NA (wild-type or
mutant) plasmid. After 96 h, 5 l of 300 l of lysate was electropho-
resed on a 9% SDS–polyacrylamide gel. For the Western blot, poly-
clonal antiserum to N9 NA was used with alkaline-phosphatase-con-
jugated second antibody. The positions of protein molecular weight
standards are indicated. (A) Serial dilutions of purified G70c virus used
as standards. The NA content was measured by densitometry of bands
on a silver-stained gel. (B) Mutant and wild-type (WT) NA in cell lysates.
The NA was measured by comparison to standards using ImageQuant
and the nanograms in each lane is indicated below.
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differences in affinity, with N200L and N329Q binding
poorly compared to the rest (Fig. 2B). The Kd can be
estimated from the inhibition curves as the concentration
at which inhibition is 50% of maximum, but is more
accurately obtained from Scatchard plots (ratio of bound
NC10 to free NC10 relative to the concentration of bound
NA; Fig. 3). The apparent Kd (negative inverse of the
slope) for the detergent-solubilized wild-type and mutant
NAs is shown in Table 2. The apparent binding constants
(Kd) for N200L and N329Q are four and six times higher,
respectively, than wild-type NA.
Lack of inhibition of NA enzyme activity indicates es-
cape from antibody neutralization, but does not neces-
sarily correlate with antibody binding; it was possible
that antibody in this assay bound to the mutants in an
altered way such that it no longer inhibited NA activity
(Tulip et al., 1989). We used an ELISA to test if inhibition
of NA by NC10 was a reflection of the degree of binding
of mutant NA by the antibody (Fig. 4). To convert the A405
ELISA reading to the amount of bound NA, we measured
NA enzyme activity in the lysates immediately before
addition to the ELISA well (total NA), and after binding
had occurred to the adsorbed NC10 (free NA). The total
NA protein was known from Western blot, giving us the
relationship between NA enzyme activity with 4-methyl-
umbelliferyl-N-acetylneuraminic acid, activity of alkaline
phosphatase in the ELISA, and ng NA. The apparent Kds
in this solid-phase assay were determined by Scatchard
analysis (Fig. 5). As expected, the affinities are higher in
the solid phase. The results (Table 2) are less precise
than those from the inhibition assays, as seen by the
lower R2 values for the linear regression analysis (Fig. 5).
For all but one of the mutants, there is a correlation
between inhibition of NA activity and binding by antibody.
The exception is mutant N329Q, which binds antibody
NC10 as well as wild-type NA, but the antibody inhibits
this mutant NA very poorly.
These results are very different to those obtained for
the NC41 epitope (Nuss et al., 1993), and more reminis-
cent of the minor effects seen when we mutated the
FIG. 2. Inhibition of wild-type and mutant NA activity by NC10. Cell lysate aliquots containing equal amounts of NA activity were preincubated with
varying amounts of NC10; then enzyme activity was measured using fetuin as substrate. A549 readings were averaged for each antibody dilution used,
and for wild-type, N329Q, S372A, N400L, K432M multiple experiments were averaged. Results are plotted as percent inhibition of NA activity. (A)
Binding curve over the full range of antibody titration to show saturation. (B) Expansion of the binding curves at low antibody concentrations to see
the differences at 50% inhibition.
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interacting amino acids on the NC41 antibody (Pruett and
Air, 1998). To see if the results can be explained by
rearrangement of side chains in the mutants to establish
stabilizing forces, we modeled each mutant in complex
with NC10 using the “Model Mutant” option of LOOK v3.0
and compared the interactions to those of the wild-type
complex. The results are shown in Fig. 6. In general, the
models show more movement of surrounding residues
compared to models of NC41 mutations. Some of the
NC41 escape mutant conformations have been con-
firmed by crystal structures (Tulip et al., 1992b), which
show alteration only at the mutant side chain. We do not
see many potential compensating H-bonds, but several
tyrosines and tryptophans have been pushed aside, in-
dicating hydrophobic interactions may substitute in the
mutants for the polar interactions of the wild-type. In
general the mutations are well accommodated, in accord
with the rather minor differences in binding of mutant NA
to NC10.
DISCUSSION
In the interaction between antibody and antigen,
shape complementarity, hydrogen bonds, van der Waals
interactions, and salt links contribute to the overall bind-
ing energy (reviewed in Davies and Cohen, 1996). Fur-
thermore, a significant percentage of contacting resi-
dues on the antibody are aromatic; often these are ty-
rosines (Padlan, 1990). Such aromatic side chains can
interact with both polar and hydrophobic groups at the
interface (Lang et al., 2000).
Novotny and co-workers used the crystal structures of
FIG. 4. (A) ELISA measuring binding of mutant NAs to NC10. The plates were coated with NC10 antibody and titrated with the cell lysates containing
known amounts of NA. Bound NA was detected with anti-G70c NA rabbit antiserum and anti-rabbit IgG conjugated with alkaline phosphatase. (B)
Correlation between A405 ELISA reading and amount of NA measured by enzyme activity using the fluorogenic substrate 4-methylumbelliferyl-N-
acetylneuraminic acid.
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antigen–antibody complexes to estimate the Gibbs free-
energy changes that occur upon formation of complex
between antibody D1.3 or HyHEL-5 and hen egg ly-
sozyme. The results suggested that only a small number
of amino acids contributed actively to binding energetics.
The concept emerged of an attractive contribution medi-
ated by the “energetic epitope” and a passive surface
complementarity contributed by the surrounding contact
area. This was experimentally demonstrated for the com-
plex of influenza N9 NA and NC41 Fab (Nuss et al., 1993).
Since then, similar energetically dominant amino acids
have been found in many cases, including in the complex
between human growth factor and human growth factor
receptor (Wells, 1996), barnase and barstar (Schreiber
and Fersht, 1993), and tissue factor and 5G9 Fab (Huang
et al., 1998). To see if the finding for N9 NA and NC41
applies to other NA–Fab complexes, we have studied
interaction of NA with another antibody where the crystal
FIG. 3. Scatchard plots of inhibition of wild-type and mutant NAs by NC10. B/F  ratio of bound NC10 to free NC10. The total concentration of NA
was from Western blot. The slope of the least-squares linear fit is equal to 1/Kd.
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structure of the complex is known, NC10. The NC10 NA
epitope overlaps the NC41 epitope almost completely,
but escape mutant analyses indicated that the amino
acids which form the energetic epitope, or critical con-
tacts, for NC41 do not play such an important role in
binding NC10 (Webster et al., 1987). To test this, we made
mutations in the NC10 epitope on N9 NA and determined
the effects of the mutation on binding antibody and
inhibiting NA activity.
Measurement of Kd
Our preliminary results indicated that the NC10
epitope may have a different energy distribution. All our
mutants could be inhibited by NC10, eventually reaching
the same level of inhibition as the wild-type NA (Fig. 2).
In contrast, mutations in the “critical” amino acids of the
NC41 epitope resulted in a complete abrogation of anti-
body binding. These results meant that for meaningful
FIG. 5. Scatchard plots of the ELISA results to determine apparent Kd in the solid phase assay.
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conclusions, we needed to determine Kds with a higher
precision than is usually attempted with proteins that are
not readily purified. We earlier developed procedures for
determining kinetic parameters of NA enzyme activity for
cell-expressed NA (Ghate and Air, 1998) and the current
results extend the analysis in several ways. First, multi-
valency is more significant to antibody binding than to
substrate interactions, so instead of carrying out the
assays on cell monolayers expressing NA, we released
NA with detergent, empirically finding conditions where
there was no loss in enzyme activity, meaning the protein
remains stably folded. As before, we measured amount
of NA protein by Western blot, but due to problems in
supply of [35S]streptavidin, we used alkaline phospha-
tase conjugated secondary antibody for detection. Digi-
tizing the bands of the Western blots using a 12-bit
Grayscale scanner and using ImageQuant for integration
gave results as reliable as Phosphorimager analysis of
35S-labeled material (Fig. 1 compared to Fig. 3 of Ghate
and Air, 1998).
To determine the NA bound in ELISA, we needed a
further assay. We knew how much NC10 was added to
the well, but not how much was bound in a configuration
able to bind NA. To determine bound NA from the A405
ELISA readings, we measured NA activity with a fluoro-
genic substrate before and after binding NC10 in the
96-well plate. These procedures all introduce errors in-
herent in the methods. These were minimized by using
multiple data sets and rigorous curve-fitting. We used the
“trendline” equations in Microsoft Excel and obtained
linear fits for the Western standard curve (band intensity
vs ng NA; R2  0.97) and NA bound in ELISA vs enzyme
activity (A405 vs F; R2  0.98), and hence A405 vs nM NA
bound (R2  0.998). Other relationships used for the Kd
determinations were nonlinear, and attempts to use the
“linear range” resulted in large errors, while fitting to
FIG. 6. Modeling the effects of mutation on the N9 NA NC10 Fab complex. The starting structure was the 2.5 Å resolution structure of Malby et al.
(1994) PDB file 1NMB. The “Model Mutant” option of Look v3.0 (Molecular Applications Group) was used to model the mutation and its neighbors.
The color and coding scheme is as follows: red for oxygen atoms; purple for nitrogen atoms; wild-type side chains in gray; modeled NA side chains
in magental; modeled NC10 in green; hydrogen bonds in dashed brown; contacts in dashed blue; thick lines are the wild-type contacts; new contacts
predicted by models are thin lines. Residues are identified by N for NA; H for heavy chain; L for light chain. We were not able to model the loss of
carbohydrate in N200L.
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polynomial curves gave acceptable R values (0.9996 for
ELISA A405 vs total NA; 0.9998 for enzyme activity vs
NA).
Apparent Kds of wild-type and mutant NAs and
modeling of the mutants
We determined Kd in two ways. The biologically rele-
vant measurement is a inhibition of enzyme activity in
solution. However, loss of inhibition does not necessarily
correlate with loss of binding, so we added an ELISA
assay. By binding NC10 to the plate, we could titrate in
the lysate containing wild-type or mutant NA. The result-
ing solid-phase apparent Kds are not the same as the
solution phase apparent Kds determined by inhibition,
but the ranking is the same.
The Kd we determined for expressed N9 NA by inhibi-
tion of enzyme activity is 6.8 nM. The mutants all showed
lower affinity, with Kds 8.9–11.9 nM for most but 26.5 and
38.5 nM for N200L and N329Q, respectively. In ELISA, the
Kds are about 1 log lower, reflecting the positive effect of
solid-phase binding. Binding constants for wild-type N9
NA with NC10 have been reported previously using pu-
rified NA “heads” released from the virus by Pronase. Our
apparent Kd of detergent-released NA by enzyme inhibi-
tion is about twofold lower than the Kd of 14.3 nM (re-
ported as Ka 7.0 
 10
7 M1) for binding of protease-
released NA to NC10 determined by sedimentation equi-
librium experiments (Gruen et al., 1993). A similar Kd of
15.9 nM (Ka 6.3 
 10
7 M1) was obtained from a Biacore
solid-phase analysis (Kortt et al., 1999), although another
Biacore study had yielded a Kd of 0.43 nM (Gruen et al.,
1993). Our “solid phase” Kd of 0.51 nM calculated from our
ELISA results is similar to this earlier estimate. A single-
chain antibody form of NC10 had much lower affinity (Kd
 32 nM) measured by Biacore analysis (Dougan et al.,
1998).
Properties of the mutants
The mutations we made were in Asn200, Asn329,
Asn345, Ser370, Ser372, Asn400, and Lys432. Replacing
Asn at position 200 removes a carbohydrate which forms
part of the epitope in the neighboring NA monomer.
Replacing Lys at position 432 with Met abolishes the salt
bridge formed with this residue. We mutated all the
remaining amino acids of the epitope that make side-
chain contacts with NC10. The remaining four contacts
only involve main-chain atoms and mutation is unlikely to
affect these interactions.
Asn200Leu. The type II (high mannose) carbohydrate
chain attached to Asn200 forms part of the epitope on a
neighboring NA monomer (Tulip et al., 1992a). This car-
bohydrate is a significant component of the epitope,
since it contributes 92 Å2 of 735 Å2, or 13%, of the total
buried surface of NA (Malby et al., 1994). The sixth sugar
residue, designated mannose 200F, contacts AspH100B
of NC10, as well as lying across the surface of NA
contacting Asn329, Arg327, and Ile366 (Fig. 6A). Surpris-
ingly for the highly polar sugar chain, the only hydrogen
bond is with ArgN327. Mannose residues 200D and 200E
also are partially buried in the antibody–antigen inter-
face. Sugar residue 200E makes van der Waals contacts
with AspN330 and ArgN364, while residue 200D hydro-
gen bonds with ArgN364. This sugar chain thus appears
to contribute to the subunit–subunit interaction, and in-
deed, when it was removed, the specific activity of NA
dropped to 19%. Removal of this carbohydrate by replac-
ing Asn of NA with Leu (N200L) caused major reduction
of both binding and inhibition by NC10, increasing the
apparent Kd fourfold in the NI test and eightfold in the
ELISA. Note that due to the low activity and binding,
there are large errors in the N200L Kds compared to
wild-type and other mutants. However, it is likely that the
loss in binding to NC10 is due to a loss of native folding
and/or assembly of NA tetramers and so we cannot
assess the contribution of the carbohydrate chain to the
epitope.
Asn329Gln. AsnN329 makes three hydrogen bonds to
NC10 Fab. Its amide N atom bonds with PheL92 carbonyl
O, and its N2 group bonds with both AspL91 O and
TyrH100A O (Malby et al., 1994). It also makes various
van der Waals contacts with the heavy chain, light chain,
and 200F mannose (Fig. 6B).
Asn329 is the only contacting residue in NA to have
been directly selected against as an escape mutant by
NC10 (Webster et al., 1987), although A369T was se-
lected when NC10 was used following NC41 selection of
S367N (Air et al., 1990). Our mutant with Gln is inhibited
weakly by NC10, with a sixfold increase in Kd. Modeling
suggests the loss of three H-bonds between NA and H
and L chains. The larger Gln side chain swings away
from AspL91 and TyrH100A, presumably due to steric
conflicts, and so breaks the hydrogen bond to the amide
N of 329. TyrL32 moves to fill in the space created by
rotation of the Gln side chain, thus removing the H-bond
to Asp 330(N) carbonyl O. However, the mutant still
retains binding to the antibody as seen in the ELISA, so
the new van der Waals contacts are equivalent to the lost
hydrogen bonds or there may be more distant compen-
sating interactions.
Ser370Thr. Malby et al. (1994) reported that the
SerN370 O hydrogen bonds with AspH56 O2. From the
structure (1MNB) we consider that this O group may be
participating in a bifurcated hydrogen bond, the other
interacting atom being AspH56 O1. An escape mutant
selected by mAb 32.3 at this position, S370L, markedly
reduced binding to NC10 (Webster et al., 1987). To ex-
amine its role more precisely, we attempted to preserve
hydrogen bonding by making a conservative change to
Thr. We were successful and S370T binds to NC10 and is
inhibited by NC10 similarly to wild-type NA.
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Ser372Ala. The O of SerN372 hydrogen bonds with
O2 of AspH56 (Malby et al., 1994). We mutated SerN372
to Ala so no hydrogen bonds could form from the mutant
side chain. However, we find that S372A can still bind to
and is inhibited by NC10 fairly well.
Asn400Leu. The N2 of Asn400 hydrogen bonds with
the OH group of TyrH52 (Malby et al., 1994), and the
carbonyl O contacts N2 of AsnH54. An escape mutant
(N400K) selected at this position by mAb NC42 retained
binding to NC10 (Webster et al., 1987). We mutated Asn to
Leu to eliminate side chain H-bonding, although the
contact between the main chain O of NA residue 400 and
the N2 of NC10 residue 54 is still present. We found that
N400L binds to NC10 less than wild-type NA; both the
inhibition Kd and the ELISA Kd are twofold higher. The
side chains of AsnN400 and TyrH99 are in van der Waals
contact. Making the side chain of residue 400 less polar
is probably increasing the van der Waals contacts, as
seen by the displacement of Tyr99(H) in the model.
Lys432Met. Electrostatic interactions are highly ener-
getically favorable and thought to be critical in protein–
antibody complexes as predicted for lysozyme (Novotny
et al., 1989) and demonstrated for NC41 (Nuss et al.,
1993). The N of LysN432 forms a salt bridge to the O1
group of AspH56 (Malby et al., 1994). An escape mutant
at this position selected in the presence of antibody
NC34 showed reduced binding to NC10 (Webster et al.,
1987). In the complex of NA with NC41, the correspond-
ing salt link was found to be necessary for antibody
recognition and K434R bound similar to wild-type NA.
Here we mutated Lys to Met to remove the positive
charge. The mutant NA bound NC10 similarly to wild-
type, although the inhibition was slightly reduced. The
modeling did not reveal how the AspH56 charge is neu-
tralized, but it is clear that the salt link from LysN432 is
not important to the NC10 epitope, in marked contrast to
its key role in the NC41 epitope (Novotny et al., 1989;
Nuss et al., 1993).
The functional epitope
Using energy calculations based on lysozyme-Fab
crystal structures, Novotny hypothesized the existence of
energetic epitopes, a small subset of residues that con-
tribute most of the binding energy (Novotny, 1991; No-
votny et al., 1989). This was first confirmed by the finding
that of the 19 contacts on G70c NA to antibody NC41, only
three centrally located residues were critical for binding
(Nuss et al., 1993). The other contacting amino acids
provided passive surface complementarity in that their
size and shape were more important than any specific
interactions. These results correlated well with selection
experiments where escape mutants grown in the pres-
ence of NC41 were only selected at three positions
(Nuss et al., 1993; Webster et al., 1987).
Mutations at the “critical contacts” of the NC41 epitope
abolished antibody binding; no matter how much NC41
was used in the titration, there was no binding (Webster
et al., 1987) or enzyme inhibition (Nuss et al., 1993)
detected. Our results (Table 2) show that the NC10
epitope is different, in that all the mutants bound NC10,
albeit with differences in affinity. Energy calculations for
the N9–NC10 complex showed somewhat lower G val-
ues than in the NC41 epitope, but predicted that the
major contributors on NA are Lys432 (3.6 kcal/mol),
Asn329 (2.2 kcal/mol), and mannose 200F (2.0 kcal/
mol) (Tulip et al., 1994). We find that Lys432 and its salt
bridge to NC10 are not important; the modeling suggests
there is considerable rearrangement of side chains to
accommodate the K432M mutation but we do not see a
substitute salt link. We cannot evaluate the role of
Man200F since loss of the carbohydrate has caused
disturbance to the structure as seen in the reduced Kcat.
Our inhibition results show that Asn329 is the most
significant contact, but N329Q binds in ELISA similarly to
wild-type so it is not at all similar to the critical contacts
in the NC41 epitope. These results are reminiscent of the
NC41 paratope, where mutations could be accommo-
dated in the interface and so had little effect on binding
(Pruett and Air, 1998).
The NC10 paratope
In an approach similar to ours for NC41 (Pruett and Air,
1998), Dougan et al. (1998) studied mutations in the NC10
paratope. Mutation of the salt-link partner of K432,
AspH56 to Asn, reduced but did not abolish binding. At
3.9 Å, the salt-link is approaching the upper distance
limit, but mutation to Glu to decrease the distance actu-
ally resulted in reduction of binding. Again, no sites were
found that were critical to the interaction; the contacting
amino acids on the antibody could all accommodate
some, although not all, substitutions.
Role of water molecules
Water is excluded from the interacting interfaces in the
NC41–NA complex, but in the NC10–NA complex several
water molecules are found in the interface (Malby et al.,
1994), where they increase the surface buried by com-
plex formation as well as increasing shape complemen-
tarity. In several crystal structures, it appears that remov-
ing water molecules from cavities would destabilize pro-
tein association (Braden and Poljak, 1995).
In the NC41 complex, mutations in the antibody se-
quence caused only minor changes in binding affinity,
but changes in the NA critical contacts were highly
disruptive to complex formation. The interpretation was
that the antibody was more flexible and so could accom-
modate changes. Influenza virus may exploit this phe-
nomenon, as single amino acid changes in the epitope
would allow the virus to escape from antibody binding
(Pruett and Air, 1998). However, the NC10 epitope can
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accommodate changes, and since this epitope largely
overlaps that of NC41, we conclude that the difference is
in the interface. It may be that N9 NA does not match the
shape of NC10 as well as NC41 and depends on water
molecules to increase the fit. Water molecules acting to
increase complementarity between two proteins has
been observed in other antigen–antibody complexes. For
example, shape complementarity between VL of Hy-
HEL-10 Fv and hen egg lysozyme is accomplished by
eight water molecules (Kondo et al., 1999). There are
three water molecules totally buried in the interface be-
tween lysozyme and D44.1 Fab (Braden et al., 1994). In
the complex between lysozyme and HyHEL-63 Fab, three
water molecules are completely buried between the two
surfaces. The water molecules in this complex not only
help fill the cavity and enhance surface complementarity,
but they also serve to bridge hydrogen bonds between
the two proteins, therefore acting as adaptors (Li et al.,
2000).
The role that water molecules play in shaping comple-
mentarity may explain why the NC10-NA interaction is
not mediated by just a small subset of critical contacts,
as was seen in the NC41–NA complex where water is
excluded. That is, complexes mediated by just a small
subset of critical contacts do not have water molecules
at the interface. For example, the hormone binding site of
the growth hormone receptor is dominated by a central
hydrophobic patch (Clackson et al., 1998). This central
region is tightly packed in the complex and does not
contain any water molecules. In the 3 Å structure of the
complex between tissue factor and 5G9 Fab, water mol-
ecules do not play a major role in the largest cavity of the
interface (Huang et al., 1998). Mutated residues in the
complex between hen egg white lysozyme (HEL) and the
anti-HEL antibody D1.3 appear to be exchanging their
interaction with each other to interact with water
(Dall’Acqua et al., 1998).
In the NC10–NA complex, three fully buried water
molecules (W301, W302, and W303) participate in some
of the hydrogen bonds across the interface (Malby et al.,
1994). Another four water molecules (W201, W229, W312,
and W317) mediate contacts between antibody and an-
tigen at the solvent-exposed perimeter of the interface.
Bogan and Thorn have compiled a database of 2325
alanine mutants for which the change in free energy of
binding upon mutation to alanine has been measured.
They found that no residue with high solvent accessibility
makes a large contribution to the free energy of binding
and concluded that for a residue to have a large impact
on the free energy of binding, it must be largely protected
from contact with bulk solvent when complexed (Bogan
and Thorn, 1998). Our results fit with this observation.
The NA-NC10 contacts in our study are solvated and
relatively weak, and so do not form a hydrophobic core.
A corollary is that there is only poor correlation between
the buried surface areas and energetic contributions of
individual side chains in interfaces (Bogan and Thorn,
1998).
The NC41 epitope is dominated by a few high-energy
interactions, predicted by calculation (Tulip et al., 1994)
and demonstrated experimentally (Nuss et al., 1993). The
calculated energies for the NA–NC10 complex were
somewhat lower than those for the NA–NC41 complex,
although the measured Kd indicated higher affinity than
NC41 (Gruen et al., 1993). Water molecules were not
included in the calculations and may explain the differ-
ence; solvation excludes high-energy interactions but
these are compensated by many low-energy ones due to
the bridging water molecules.
Our mutagenesis results can thus be explained by
solvation in the interface. Water molecules promote the
formation of the NA–NC10 complex by providing extra
contacts, but at the same time the water excludes high
energy contacts so that any single mutation has only a
modest effect on the binding of NC10 to NA.
MATERIALS AND METHODS
Viruses and cells
The influenza virus was a reassortant virus made to
facilitate purification of NA (Laver et al., 1984), A/NWS/
33HA–tern/Australia/G70c/75NA (H1N9), referred to as
NWS-G70c. It contains the HA gene from A/NWS/33 and
the NA gene from A/tern/Australia/G70c/75. A cloned,
full-length cDNA copy of the NA gene isolated from this
reassortant has been described (Air et al., 1985). For
transient expression of proteins, HeLa cells were grown
in DMEM containing 10% supplemented calf serum (Hy-
Clone), 1% glutamine, 1% sodium pyruvate, 1% kanamy-
cin sulfate, and 1% penicillin/streptomycin.
Antibodies
A rabbit polyclonal antiserum generated against puri-
fied N9 NA was generously provided by W. G. Laver. To
reduce nonspecific binding in Western blots, 50 l of this
antiserum was preadsorbed to an equal volume of puri-
fied A/NWS/33HA-Memphis/31/98NA (H1N2) influenza vi-
rus in 2 ml PBS for 1 h with rocking at room temperature.
The virus was spun out at 50,000 rpm in a TLS-55 rotor or
at 62,600 rpm in a TLA 100.3 rotor for 1 h at 4°C and the
supernatant used in Western blots. The NC10 hybridoma
cell line was generously provided by R. G. Webster.
Hybridomas were grown and antibodies purified as pre-
viously described (Pruett and Air, 1998).
Mutagenesis
The structure of NC10 Fab complexed with G70c NA
[PDB file 1NMB (Malby et al., 1994)] was examined for
NA contacts that were centrally or peripherally located in
the epitope using MacImdad v.5.2, (Molecular Applica-
tions Group, Palo Alto, CA). MacImdad defines a hydro-
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gen bond as a close contact between an acceptor oxy-
gen atom and a donor nitrogen atom, the O—N distance
being less than 3.6 Å and the C—O—N angle being
more than 90°.
Stratagene’s Chameleon Double-Stranded Site-Di-
rected Mutagenesis Kit or QuikChange Kit was used to
mutagenize NA genes. Mutagenic oligonucleotides were
named according to the original amino acid, its position,
and the residue to which it is changed; the bases re-
sponsible for the change are underlined. The following
oligonucleotides were used:
N9-N200L, 5-CAGGCCCGAACAATCTCGCATCAGCA-
GTGATCTG-3;
N9-N329Q, 5-GATAACCCCCGACCGCAAGACCCAAC-
TGTAG-3;
N9-N345Q, 5-CCCTTATCCAGGCAATCAGAACAATGG-
GGTCAAAG-3;
N9-S370T, 5-GACAATAAGCATAGCTACCAGATCCGG-
ATATG-3;
N9-S372A, 5-GCATAGCTTCAAGAGCGGGATATGAGA-
TGC-3;
N9-N400L, 5-CAGACAATCGTCTTACTCACTGACTGG-
AGTG-3;
N9-K432M, 5-GTGGGAGACCTATGGAGGATAAAGTG-
TGGTG-3.
All mutants were sequenced over the full NA coding
region using an ABI/Prism DNA Sequencer with dye-
labeled terminators. The oligonucleotide primers used
are as follows:
G70c-240, 5-CATTCAGGTAGAGGA-3;
G70c-492, 5-CCTAATAAGCTGGCC-3;
G70c-729, AGTCTGCCCGGTAGT-3;
G70c-963. 5-TAGTCAGTATATATG-3;
G70c-1155, 5-GGTGCCAAATGCATT-3;
N9–1309M, 5-GGGAGACCTCGGGAGGATAA-3.
Protein expression
Mutant NAs were expressed from the pBluescript vec-
tor (Stratagene) under control of the T7 promoter using
the vaccinia virus-T7 polymerase transient expression
system (Felgner et al., 1987; Fuerst et al., 1986). Thirty-
five-millimeter plates of just-confluent HeLa cells were
infected at 37°C with 0.1–1.0 m.o.i. recombinant vaccinia
virus expressing T7 polymerase (vvTF7-3) diluted in cal-
cium magnesium phosphate-buffered saline (0.4 g KCl,
0.4 g KH2PO4, 0.2 g MgCl2  6H2O, 16 g NaCl, 4.3 g
Na2HPO4  7H2O, 10 mg phenol red, and 20 mL 0.09 M
CaCl2 in 2 l H2O, pH 7.2) with 0.1% bovine serum albumin
(BSA). The virus was adsorbed for 45 min, then the cells
were washed twice with serum-free DMEM and trans-
fected with the Bluescript-N9 NA plasmid using Lipofec-
tin (BRL). The plasmid transfection mix was prepared as
follows: 2 g of the mutant plasmid DNA and 15 l
lipofectin (BRL) were diluted in polystyrene tubes in 300
and 400 l, respectively, of serum-free DMEM. The lipo-
fectin mix was then added dropwise to the DNA mix.
After an incubation period of 15 min at room temperature,
the mixture was added to the cells previously infected
with vvTF7-3, and 300 l of serum-free DMEM was
added for a final volume of 1 ml immediately.
Wells of cells were transfected in triplicate. After 96 h
the transfected cells were washed, moistened with 50 l
calcium magnesium saline (1.2 g boric acid, 0.05 g
Na2B4O7  10H2O, 8.5 g NaCl, 0.17 g MgCl2  6H2O, 0.028
g CaCl2 in 1 L H2O, pH 7.2), and lysed on the plate by
addition of 25 l Western lysis buffer (10 mM Tris pH 7.4,
1% Triton X-100, 0.4% sodium deoxycholate, 20 mM
EDTA, 10% sucrose) for 5 min at room temperature. Cal-
cium magnesium saline (225 l) was then added to each
lysate and the total lysate was collected. The nuclei were
spun out at 14,000 rpm for 5 min at 4°C and the super-
natant was used for the neuraminidase assays, neura-
minidase-inhibition (NI) assays, ELISA assays, and West-
ern blotting.
Western blotting
We quantitated the amount of NA expressed from the
HeLa cells by Western blots. Three microliters of 10%
SDS, bromphenol blue, 1 l 2-mercaptoethanol, and ap-
proximately 8 mg urea crystals was added to 5 l of the
lysate. This mixture was boiled for 3 min and then was
loaded onto a 9% polyacrylamide–SDS gel. For quantita-
tion, we used purified NWS-G70c virus, 1 l of each of a
range of dilutions treated in the same way. After electro-
phoresis, the proteins were transferred to Immobilon
membrane using a Bio-Rad TransBlot cell and probed for
NA. The procedure for Western blotting was as given for
the Anti-Xpress Antibody (Invitrogen), blocking with Tris-
buffered saline (20 mM Tris–HCl, 140 mM NaCl, pH 7.5)
 5% dry milk and then reacting with antibodies as
follows: The primary antibody was 800 l of anti-G70c
NA antiserum, preadsorbed and diluted as described
above, and the secondary antibody was 2 l anti-rabbit
IgG conjugated with alkaline phosphatase (Southern Bio-
technology). The blots were developed with 10 ml bro-
mochloroindolyl phosphate and nitroblue tetrazolium
substrate solution (Sigma). Since the anti-G70c anti-
serum is polyclonal, the Western blot measures the total
amount of native and unfolded NA. The membranes were
scanned using an Astra UMAX 1200 scanner attached to
an iMac and Macintosh Adobe PhotoDeluxe software set
to 12 bit grayscale, at 300 pixels/inch. The bands were
quantitated using ImageQuant software (Molecular Dy-
namics); a standard curve was constructed, and
amounts of NA protein in the lysates were determined.
To determine how much of the total protein of NWS-
G70c virus is NA, we silver stained a protein gel con-
taining lanes of different amounts of purified virus using
a modified procedure (Wray et al., 1981). The stained
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bands corresponding to influenza proteins were digitized
and quantitated as described for the Western blot. The
percentage of NA in the virus is approximately 5  5%
and was used to relate NA to total viral protein in the
Western blot. The molecular weight of an NA monomer
was taken as 54,000 (this excludes carbohydrate, which
is not measured in the Bio-Rad assay).
Neuraminidase activity
The enzyme activity of each mutant NA was deter-
mined using a scaled-down version of the Warren color-
imetric assay for released sialic acid (Nuss et al., 1993);
the hydrolysis of 32 nmol sialic acid produces an A549
close to 1.0. Thus we could measure the enzyme activity
of the lysates containing wild-type and mutant NA; then
using the NA content determined by Western blot, we
could calculate the specific activity. Kcat was calculated
from enzyme activity with fetuin as substrate under initial
velocity conditions together with the amount of NA as
determined by Western blot. We calculated the Kcat per
active site (one monomer of NA). We had previously
determined that the enzyme activity was stable to the
detergents in the lysis buffer.
Neuraminidase inhibition (NI) assays
An amount of lysate containing wild-type or mutant NA
which released about 30 nmol sialic acid from fetuin after
30 min incubation was titrated with NC10. Each lysate
was preincubated with 0.017 to 17.35 M purified NC10
mAb for 10 min before adding fetuin substrate. The per-
centage inhibition (fraction bound) was calculated and
hence Kd determined.
Enzyme-linked immunosorbent assay (ELISA)
Binding of NC10 mAb to G70c NA was analyzed by
ELISA. The wells of a 96-well microtiter plate were
coated with NC10 mAb (10 g/ml in carbonate/bicarbon-
ate coating buffer, 50 l per well), incubated at 4°C
overnight, and washed three times with phosphate-buff-
ered saline (8 g NaCl, 0.2 g KH2PO4, 2.9 g Na2HPO4 
12H2O, 0.2 g KCl, and 0.2 g NaN3 in 1 L H2O, pH 7.4)
containing 0.05% Tween. Nonspecific binding was
blocked with 2% dry milk in PBS (100 l per well) for 1 h
at room temperature. After washing, individual NA wild-
type and mutant lysates were added in twofold serial
dilutions (diluted into 1% dry milk in PBS, 50 l in each
well) and incubated for 4 h at 37°C. This was followed
after washing by addition of anti-G70c N9 rabbit anti-
serum (diluted 1:1000 in 1% dry milk, 50 l in each well)
and incubated for 4 h at 37°C. Anti-rabbit IgG conjugated
with alkaline phosphatase was then added (diluted
1:1000 in 1% dry milk, 50 l per well). Finally, Sigma 104
phosphatase substrate was added (1 mg/ml in dietha-
nolamine buffer, 50 l per well) and incubated until
sufficient color had developed (approximately 20 min);
then the absorbance was read at 405 nm. Since the
ELISA uses the monoclonal antibody NC10, it measures
binding of native NA to NC10.
To relate the measured A405 to amount of NA bound,
we measured enzyme activity of the N345Q lysate dilu-
tions with the fluorogenic substrate, 4-methylumbel-
liferyl-N-acetyl neuraminic acid, determining activity be-
fore (total NA) and after binding to NC10 (free NA). Thus
we could relate the A405 reading to amount of NA.
Calculation of Kd
The dissociation constant for binding of wild-type and
mutant NAs to NC10 antibody was determined in several
ways.
Enzyme inhibition curve. The concentration of ligand at
which the receptor is half saturated is the Kd.
Enzyme inhibition: Scatchard. When the ratio of bound
to free antibody is plotted against bound antibody, the
negative inverse of the resulting slope is equal to Kd.
ELISA with A405 related to [NA] by enzyme activity.When
the ratio of bound-to-free NA is plotted against bound NA,
the negative inverse of the resulting slope is equal to Kd.
Modeling
The structure of NC10 Fab complexed with N9 NA,
PDB file 1NMB (Malby et al., 1994) served as the frame-
work for modeling the NA mutants via the program LOOK
(v2.0, 1995, Molecular Applications Group). Although the
whale virus NA in this structure differs from G70c NA by
14 amino acids (Air et al., 1987), none are in the epitope.
We used the subroutine Model Mutant including the
mutated amino acid and 10 neighboring amino acids.
Model Mutant uses the wild-type as the backbone of the
model to be produced, optimizing only side-chain pack-
ing. We used the default parameters in LOOK to define
hydrogen bonds: O—N distance less than 3.6 Å and the
CAO—N angle greater than 90°.
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